drugset / Trial / NCT00532675
Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma.
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will evaluate the safety of LBH589 given in combination with lenalidomide and dexamethasone in adult patients with multiple myeloma
Timeline
- Start
- 2008-04-22
- Primary completion
- 2017-11-08
- Completion
- 2017-11-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Panobinostat | Small molecule | 5 mg | — |
| Subject | Panobinostat | Small molecule | 10 mg | — |
| Subject | Panobinostat | Small molecule | 20 mg | — |
| Subject | Panobinostat | Small molecule | 25 mg | — |
| Background | Lenalidomide | Other / unclassified | — | — |